Quantitative determination of environmental levels of uranium, thorium and plutonium in bone by solvent extraction and alpha spectrometry

Autor: M. E. Wrenn, Laura L. Lewis, Carol J. Zimmerman, N. P. Singh

Publikováno v: Nuclear Instruments and Methods in Physics Research. 223:558-562

Solvent extraction and alpha-spectrometry have been emplyed in the quantitative simultaneous determination of uranium. thorium and plutonium. The bone specimens, spiked with 232 U, 229 Th and 242 Pu tracers, are wet ashed with HNO 3 followed by alter

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::e75618cc4420d467a26eb2e623f7cd2f
https://doi.org/10.1016/0167-5087(84)90709-9

Uranium, Thorium and Plutonium in Bones from the General Population of the United States

Autor: Laura L. Lewis, N. P. Singh, M. E. Wrenn

Publikováno v: Metals in Bone ISBN: 9789401086806

This paper describes the concentrations of alpha-emitting isotopes of thorium (228Th, 230Th and 232Th), uranium (234U, 235U and 238U) and plutonium (238Pu, 239,240Pu) in vertebrae, ribs and sternum from former residents of two areas in the United Sta

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::2301a9dbbddbd55bb9dc23d4cea75759
https://doi.org/10.1007/978-94-009-4920-1_22

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Mesoscale Brain Mapping: Bridging Scales and Modalities in Neuroimaging - A Symposium Review.

Autor: Marchant JK; Harvard-MIT Division of Health Sciences and Technology, Cambridge, MA, USA. jmarchan@mit.edu.; Athinoula A. Martinos Center for Biomedical Imaging, Charlestown, MA, USA. jmarchan@mit.edu., Ferris NG; Harvard-MIT Division of Health Sciences and Technology, Cambridge, MA, USA. nferris@mit.edu.; Harvard Biophysics Graduate Program, Cambridge, MA, USA. nferris@mit.edu., Grass D; Harvard-MIT Division of Health Sciences and Technology, Cambridge, MA, USA.; Massachusetts Institute of Technology, Cambridge, MA, USA., Allen MS; Massachusetts Institute of Technology, Cambridge, MA, USA.; Massachusetts General Hospital, Boston, MA, USA., Gopalakrishnan V; Harvard-MIT Division of Health Sciences and Technology, Cambridge, MA, USA.; Massachusetts Institute of Technology, Cambridge, MA, USA., Olchanyi M; Harvard-MIT Division of Health Sciences and Technology, Cambridge, MA, USA.; Massachusetts General Hospital, Boston, MA, USA., Sehgal D; Harvard-MIT Division of Health Sciences and Technology, Cambridge, MA, USA.; Massachusetts General Hospital, Boston, MA, USA., Sheft M; Harvard-MIT Division of Health Sciences and Technology, Cambridge, MA, USA.; Massachusetts General Hospital, Boston, MA, USA., Strom A; Harvard-MIT Division of Health Sciences and Technology, Cambridge, MA, USA.; Athinoula A. Martinos Center for Biomedical Imaging, Charlestown, MA, USA., Bilgic B; Massachusetts General Hospital, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA., Edlow B; Athinoula A. Martinos Center for Biomedical Imaging, Charlestown, MA, USA.; Massachusetts General Hospital, Boston, MA, USA., Hillman EMC; Mortimer B. Zuckerman Mind Brain Behavior Institute, Columbia University, New York, NY, USA.; Department of Biomedical Engineering, Columbia University, New York, NY, USA.; Department of Radiology, Columbia University, New York, NY, USA., Juttukonda MR; Massachusetts General Hospital, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA., Lewis L; Harvard-MIT Division of Health Sciences and Technology, Cambridge, MA, USA.; Massachusetts Institute of Technology, Cambridge, MA, USA., Nasr S; Massachusetts General Hospital, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA., Nummenmaa A; Massachusetts General Hospital, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA., Polimeni JR; Massachusetts General Hospital, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA., Tootell RBH; Massachusetts General Hospital, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA., Wald LL; Massachusetts General Hospital, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA., Wang H; Athinoula A. Martinos Center for Biomedical Imaging, Charlestown, MA, USA.; Massachusetts General Hospital, Boston, MA, USA., Yendiki A; Massachusetts General Hospital, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA., Huang SY; Athinoula A. Martinos Center for Biomedical Imaging, Charlestown, MA, USA.; Massachusetts General Hospital, Boston, MA, USA., Rosen BR; Massachusetts General Hospital, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA., Gollub RL; Massachusetts General Hospital, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.

Publikováno v: Neuroinformatics [Neuroinformatics] 2024 Oct; Vol. 22 (4), pp. 679-706. Date of Electronic Publication: 2024 Sep 23.

Doping Prevalence among U.S. Elite Athletes Subject to Drug Testing under the World Anti-Doping Code.

Autor: Davoren AK; Prevention Strategies, Greensboro, NC, USA. akdavoren@preventionstrategies.com., Rulison K; Prevention Strategies, Greensboro, NC, USA., Milroy J; The University of North Carolina Greensboro, Greensboro, NC, USA., Grist P; The University of North Carolina Greensboro, Greensboro, NC, USA., Fedoruk M; U.S. Anti-Doping Agency (USADA), Colorado Springs, CO, USA., Lewis L; U.S. Anti-Doping Agency (USADA), Colorado Springs, CO, USA., Wyrick D; Prevention Strategies, Greensboro, NC, USA.; The University of North Carolina Greensboro, Greensboro, NC, USA.

Publikováno v: Sports medicine - open [Sports Med Open] 2024 May 20; Vol. 10 (1), pp. 57. Date of Electronic Publication: 2024 May 20.